Dupilumab does not affect correlates of vaccine-induced immunity: A randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis
Journal of the American Academy of Dermatology | Aug 10, 2018
Ixekizumab provides superior efficacy compared to ustekinumab over 52-weeks of treatment: Results from IXORA-S, a phase 3 study
Journal of the American Academy of Dermatology | Jul 05, 2018
A dose-finding study for hemoporfin in photodynamic therapy for port-wine stain: A multicenter randomized double-blind phase IIb trial
Photodermatology, Photoimmunology and Photomedicine | Jun 21, 2018
Safety and efficacy of hydrogen peroxide topical solution, 40% (w/w) in patients with seborrheic keratoses: Results from two identical, randomized, double-blind, placebo-controlled, phase 3 studies (A-101-SEBK-301/302)
Journal of the American Academy of Dermatology | Jun 06, 2018
Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study
Journal of the American Academy of Dermatology | Jun 06, 2018